By Karen Roman
MOBILion Systems, Inc. revealed its hi-res mass spectrometry functionality with implementations for proteomics, metabolomics and lipidomics, among others.
The company’s approach is up to 5-10 times faster than current systems, close to 100% ion utilization efficiency and it increases specificity for separating complex compounds, it said.
The innovation has further implications for drug discovery, personalized medicine, environmental protection, and more.
“This is a pivotal development for MOBILion that we have been building toward since MOBILion’s inception,” said Melissa Sherman, MOBILion’s CEO. “Replacing slow, inefficient, lossy quadrupole isolation with high-resolution mobility separation provides unmatched speed and peak capacity and represents a paradigm shift in mass spectrometry, one that will redefine the industry for decades to come and open doors to untold scientific discoveries across countless disciplines.”
Contact:
Editor@executives-edge.com
